| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/23/2009 | CN101606916A Pharmaceutical formulations of modafinil |
| 12/23/2009 | CN101606915A Novel pharmaceutical formulations of modafinil |
| 12/23/2009 | CN101606914A Cefuroxime axetil tablet preparation suitable for direct powder compression |
| 12/23/2009 | CN101606913A Cefixime dispersing tablet and preparation methods thereof |
| 12/23/2009 | CN101606912A Nitazoxanide parasite expelling tablet for pets and preparation method thereof |
| 12/23/2009 | CN101606911A Risperidone dripping pill and preparing method thereof |
| 12/23/2009 | CN101606909A Amoxicillin powder injection and preparation method thereof |
| 12/23/2009 | CN101606908A Decoquinate soluble powder and preparation method thereof |
| 12/23/2009 | CN101606907A Fotemustine solid lipid nanoparticle and preparation method thereof |
| 12/23/2009 | CN101606906A Ursodeoxycholic acid nano suspension and preparation method thereof |
| 12/23/2009 | CN101606905A Nitazoxanide suspension for expelling parasite in livestock body and preparation method thereof |
| 12/23/2009 | CN101606902A Contraceptive vagina gel with function of killing microorganism |
| 12/23/2009 | CN100572542C Systemic viral/ligand gene delivery system and gene therapy |
| 12/23/2009 | CN100571784C Chewing article |
| 12/23/2009 | CN100571783C Glipizide controlled release tablets and preparation method thereof |
| 12/23/2009 | CN100571782C Water-soluble chitosan microsphere for carrying medicament and preparation thereof |
| 12/23/2009 | CN100571781C Biotinylated pulullan polysaccharide nanometer grains and the preparation method |
| 12/23/2009 | CN100571780C Nano composite material of quaternary ammonium salt of chitosan/rectorite, and preparation method |
| 12/23/2009 | CN100571779C Alginate nano capsule and its preparing method |
| 12/23/2009 | CN100571778C Preparation method of Chitosan pellet having bioactivity medicine |
| 12/23/2009 | CN100571760C Prescription of mouth ulcer bilayer film and technique of preparing the same |
| 12/23/2009 | CN100571715C Compositions containing bioactive materials, methods of preparation and treatment |
| 12/23/2009 | CN100571710C Medicine preparation for treating severe myasthenia |
| 12/23/2009 | CN100571703C Sustained-release micro-pellet of trimetazidine and preparation process thereof |
| 12/23/2009 | CN100571700C Carbazochrome sodium sulfonate slow-released tablet and its preparing method |
| 12/23/2009 | CN100571697C Drop pills of seabuckthorn fruit flavone |
| 12/23/2009 | CN100571695C Bilayer pharmaceutical tablets comprising telmisartan and diuretic and their preparation |
| 12/23/2009 | CN100571693C Medicinal composition containing ibuprofen |
| 12/23/2009 | CN100571688C Medicine-loading sustained-release micro-capsule and preparing method thereof |
| 12/23/2009 | CN100571684C Method for preparing high content beta-carotene water soluble nanometer particles |
| 12/23/2009 | CN100571683C Dry suspension and its preparation process |
| 12/23/2009 | CN100571682C Process for producing microparticles |
| 12/23/2009 | CN100571679C Lidocaine hydrochloride partial film forming gel composition and uses thereof |
| 12/23/2009 | CA2852177A1 Glucagon/glp-1 receptor co-agonists |
| 12/23/2009 | CA2728975A1 Composition for transdermal delivery of cationic active agents |
| 12/23/2009 | CA2728325A1 Topical composition for controlling ectoparasites in dogs and cats |
| 12/23/2009 | CA2728202A1 Composition for addition to drinking water |
| 12/23/2009 | CA2728131A1 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 12/23/2009 | CA2727935A1 Preparation of controlled release skeletal muscle relaxant dosage forms |
| 12/23/2009 | CA2727428A1 Drug carrier |
| 12/23/2009 | CA2726161A1 A peptide derivative and a composition for promoting lacrimal secretion comprising the same |
| 12/23/2009 | CA2725523A1 Self-preserved emulsions |
| 12/23/2009 | CA2725487A1 A pharmaceutical composition |
| 12/22/2009 | US7635789 Fluoroalkyl acid amide surfactants |
| 12/22/2009 | US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 12/22/2009 | US7635734 Photochemical activation of surfaces for attaching biomaterial |
| 12/22/2009 | US7635692 In form of concentrate or dietary composition such as fortified foods, fortified feed and beverages, or in the form of different galenical formulations such as tablets, granules filled into capsules, or effervescent formulations |
| 12/22/2009 | US7635686 Cancer treatment with a synthetic sequences |
| 12/22/2009 | US7635675 Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| 12/22/2009 | US7635490 Modified release dosage form |
| 12/22/2009 | US7635486 Where lipidation thereof is from expression of first nucleic acid sequence and protein portion thereof is from expression of second nucleic acid sequence and first and second sequences do not naturally occur together, such as a lipoprotein where first sequence encodes Borrelia lipoprotein, second, PsaA |
| 12/22/2009 | US7635464 Selective targeting of apoptotic cells |
| 12/22/2009 | CA2567857C Irinotecan liposome formulation |
| 12/22/2009 | CA2562329C Therapeutic antimicrobial compositions and methods |
| 12/22/2009 | CA2523734C Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients |
| 12/22/2009 | CA2492954C Pegylated t1249 polypeptide |
| 12/22/2009 | CA2473662C Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 12/22/2009 | CA2451106C Sequential drug delivery systems |
| 12/22/2009 | CA2447166C Delivery of erectile dysfunction drugs through an inhalation route |
| 12/22/2009 | CA2446990C Delivery of sedative-hypnotics through an inhalation route |
| 12/22/2009 | CA2446917C Delivery of antipsychotics through an inhalation route |
| 12/22/2009 | CA2446916C Delivery of opioids through an inhalation route |
| 12/22/2009 | CA2419065C Lactic acid polymer and process for producing the same |
| 12/22/2009 | CA2415386C Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 12/22/2009 | CA2406536C Preparation of injectable suspensions having improved injectability |
| 12/22/2009 | CA2406081C Administration of a thiol-based chemoprotectant compound |
| 12/22/2009 | CA2402421C Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 12/22/2009 | CA2399000C Osmotically-driven fluid dispenser and coating composition |
| 12/22/2009 | CA2395987C Improved pharmaceutical formulations |
| 12/22/2009 | CA2391008C Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds |
| 12/22/2009 | CA2375241C Stabilizer for pharmacons |
| 12/22/2009 | CA2373909C Multilayer drug form release in the colon |
| 12/22/2009 | CA2369587C Solubilized pharmaceutical composition for parenteral administration |
| 12/22/2009 | CA2345492C Methods and apparatus for improved administration of pharmaceutically active compounds |
| 12/22/2009 | CA2344372C Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same |
| 12/22/2009 | CA2343325C Topical dermal antimicrobial compositions |
| 12/22/2009 | CA2339192C Treatment of addiction and addiction-related behavior |
| 12/22/2009 | CA2338440C Foam composite for the repair or regeneration of tissue |
| 12/22/2009 | CA2327465C Bipolar lipids capable of delivering polyanions to cells |
| 12/22/2009 | CA2324117C Process for preparing a noncrystallizable polyol syrup |
| 12/22/2009 | CA2303973C Prolonged release formulation of carbamazepine |
| 12/22/2009 | CA2276267C Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 12/22/2009 | CA2205022C Adjuvant for a vaccine composition |
| 12/22/2009 | CA2185802C Hydrophobic drug delivery systems |
| 12/22/2009 | CA2145761C Nucleic acid ligands and methods for producing the same |
| 12/22/2009 | CA2133833C Method and kit for imaging and treating organs and tissues |
| 12/20/2009 | CA2637538A1 Dar 1 (dermal acne remover) |
| 12/17/2009 | WO2009152479A1 Compositions comprising nitric oxide or nitric oxide donors for the treatment of neurodegenerative diseases of trauma |
| 12/17/2009 | WO2009152347A2 Crystalline forms of zotepine hydrochloride |
| 12/17/2009 | WO2009152167A2 Delivery of therapeutics |
| 12/17/2009 | WO2009152144A2 All day rhinitic condition treatment regimen |
| 12/17/2009 | WO2009152128A1 Pegylated insulin lispro compounds |
| 12/17/2009 | WO2009152041A2 Controlled release formulations of pramipexole |
| 12/17/2009 | WO2009151974A1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 12/17/2009 | WO2009151708A2 Peptide analogs of alpha-melanocyte stimulating hormone |
| 12/17/2009 | WO2009151687A2 Dendrimer conjugates |
| 12/17/2009 | WO2009151627A2 Endosome-disrupting compostions and conjugates |
| 12/17/2009 | WO2009151590A2 Methods of treating cyp2d6 alternative metabolizers |
| 12/17/2009 | WO2009151090A1 Rapidly disintegrating preparation containing calcium carbonate |
| 12/17/2009 | WO2009151072A1 Tablet quickly disintegrating in the oral cavity and method for producing the same |